Cargando…
Suppression of Drug Resistance in Dengue Virus
Dengue virus is a major human pathogen responsible for 400 million infections yearly. As with other RNA viruses, daunting challenges to antiviral design exist due to the high error rates of RNA-dependent RNA synthesis. Indeed, treatment of dengue virus infection with a nucleoside analog resulted in...
Autores principales: | Mateo, Roberto, Nagamine, Claude M., Kirkegaard, Karla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Microbiology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701834/ https://www.ncbi.nlm.nih.gov/pubmed/26670386 http://dx.doi.org/10.1128/mBio.01960-15 |
Ejemplares similares
-
Targeting intramolecular proteinase NS2B/3 cleavages for trans-dominant inhibition of dengue virus
por: Constant, David A., et al.
Publicado: (2018) -
My Cousin, My Enemy: quasispecies suppression of drug resistance
por: Kirkegaard, Karla, et al.
Publicado: (2016) -
A Targeted Computational Screen of the SWEETLEAD Database Reveals FDA-Approved Compounds with Anti-Dengue Viral Activity
por: Moshiri, Jasmine, et al.
Publicado: (2020) -
Dominant drug targets suppress the emergence of antiviral resistance
por: Tanner, Elizabeth J, et al.
Publicado: (2014) -
Transmission genetics of drug-resistant hepatitis C virus
por: van Buuren, Nicholas, et al.
Publicado: (2018)